CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 75 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q1 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $108 | -99.9% | 986,072 | -0.2% | 0.00% | – |
| Q3 2022 | $163,000 | -34.5% | 988,419 | 0.0% | 0.00% | – |
| Q2 2022 | $249,000 | -56.0% | 988,419 | -7.3% | 0.00% | – |
| Q1 2022 | $566,000 | -34.0% | 1,066,781 | -23.5% | 0.00% | – |
| Q4 2021 | $858,000 | -39.3% | 1,393,897 | +0.6% | 0.00% | – |
| Q3 2021 | $1,413,000 | -43.1% | 1,386,108 | +2.1% | 0.00% | – |
| Q2 2021 | $2,484,000 | -21.5% | 1,357,449 | -15.6% | 0.00% | – |
| Q1 2021 | $3,166,000 | +81.1% | 1,607,521 | +14.9% | 0.00% | – |
| Q4 2020 | $1,748,000 | -23.2% | 1,398,790 | +10.7% | 0.00% | – |
| Q3 2020 | $2,275,000 | -71.3% | 1,263,982 | +33.8% | 0.00% | -100.0% |
| Q2 2020 | $7,922,000 | +52.6% | 944,369 | -4.7% | 0.00% | +100.0% |
| Q1 2020 | $5,190,000 | -39.1% | 990,587 | -36.5% | 0.00% | 0.0% |
| Q4 2019 | $8,516,000 | +134.3% | 1,559,910 | +109.0% | 0.00% | 0.0% |
| Q3 2019 | $3,634,000 | -24.6% | 746,212 | +7.3% | 0.00% | 0.0% |
| Q2 2019 | $4,821,000 | +9.8% | 695,675 | +10.1% | 0.00% | 0.0% |
| Q1 2019 | $4,391,000 | -30.7% | 631,874 | -41.8% | 0.00% | 0.0% |
| Q4 2018 | $6,338,000 | +63.3% | 1,085,444 | +111.1% | 0.00% | 0.0% |
| Q3 2018 | $3,881,000 | +55.9% | 514,140 | +4.3% | 0.00% | 0.0% |
| Q2 2018 | $2,490,000 | -1.3% | 493,070 | +19.2% | 0.00% | 0.0% |
| Q1 2018 | $2,524,000 | -13.1% | 413,811 | +1.1% | 0.00% | 0.0% |
| Q4 2017 | $2,905,000 | +9.4% | 409,365 | +10.2% | 0.00% | 0.0% |
| Q3 2017 | $2,655,000 | +49.0% | 371,371 | +31.3% | 0.00% | 0.0% |
| Q2 2017 | $1,782,000 | +7.4% | 282,862 | +40.6% | 0.00% | 0.0% |
| Q1 2017 | $1,659,000 | +13.7% | 201,177 | +16.5% | 0.00% | 0.0% |
| Q4 2016 | $1,459,000 | +24.8% | 172,685 | +0.3% | 0.00% | 0.0% |
| Q3 2016 | $1,169,000 | +172.5% | 172,201 | +19.9% | 0.00% | – |
| Q2 2016 | $429,000 | +160.0% | 143,582 | +57.4% | 0.00% | – |
| Q1 2016 | $165,000 | +10.0% | 91,235 | 0.0% | 0.00% | – |
| Q4 2015 | $150,000 | +4.9% | 91,235 | 0.0% | 0.00% | – |
| Q3 2015 | $143,000 | – | 91,235 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $1,273,000 | 0.73% |
| ETF MANAGERS GROUP, LLC | 7,062,485 | $1,787,000 | 0.05% |
| Ikarian Capital, LLC | 862,527 | $217,000 | 0.04% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 457,209 | $115,000 | 0.02% |
| Platform Technology Partners | 33,750 | $9,000 | 0.01% |
| PINNACLE ASSOCIATES LTD | 910,006 | $230,000 | 0.01% |
| CJM Wealth Advisers, Ltd. | 30,465 | $7,683 | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 4,029,171 | $1,016,000 | 0.00% |
| Vident Investment Advisory, LLC | 267,612 | $67,000 | 0.00% |
| Aries Wealth Management | 15,400 | $4,000 | 0.00% |